Please login to the form below

Not currently logged in
Email:
Password:

diabetic macular oedema

This page shows the latest diabetic macular oedema news and features for those working in and with pharma, biotech and healthcare.

After Lucentis setback, Novartis trumpets data on follow-up drug

After Lucentis setback, Novartis trumpets data on follow-up drug

The experimental therapy – called brolucizumab (RTH258) – showed its was superior to a Bayer and Regeneron’s Eylea (aflibercept) in tackling a key disease activity marker in age-related macular degeneration (AMD), ... In addition to nAMD, Novartis

Latest news

More from news
Approximately 3 fully matching, plus 23 partially matching documents found.

Latest Intelligence

  • Diagnosed Anywhere Diagnosed Anywhere

    The system creates an immediate, reliable assessment for diabetic retinopathy, including macular oedema, during a routine office visit in a primary care setting. ... The diagnostic report includes treatment advice aligned with the American Academy of

  • Medius Deal Watch table for February 2015 Medius Deal Watch table for February 2015

    Majority acquisition. 380. Pfenex/ Hospira. PF582 -  LUCENTIS biosimilar candidate - wet age-related macular degeneration, diabetic macular oedema.

  • Allergan and taking a specialised approach Allergan and taking a specialised approach

    spasticity associated with stroke and for the ophthalmology treatment Ozurdex in diabetic macular oedema.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics